At a glance
ClinicalIndex Comparison RecordN/ACompleted· 570 enrolled
Drug / intervention
GLUMA (Kulzer GmbH, Germany) desensitizing agentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Gluma Desensitizer in Controlling the Immediate Post-treatment Sensitivity in Etch-and-rinse and Self-etch Adhesive Bonded Occlusal Composite Restorations
In Brief
A clinical study evaluating GLUMA (Kulzer GmbH, Germany) desensitizing agent for Sensitivity, Tooth. Completed, enrolled 570 participants across 1 site.
Detailed Summary
To evaluate the effect of Gluma desensitizer in controlling immediate post-treatment sensitivity in posterior occlusal composite restorations.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSensitivity, Tooth
CountriesIndia
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartFeb 2020
Primary CompletionFeb 2025
TodayJul 2026
First PostedJan 30, 2020
Enrollment StartFeb 6, 2020
Primary CompletionFeb 20, 2025
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 6.4 years ago
Interventions
GLUMA (Kulzer GmbH, Germany) desensitizing agentother
GLUMA desensitizer is used to reduce tooth sensitivity